Human Regenerator — Cold Atmospheric Plasma

The Human Regenerator Power Jet at REGEVITA uses cold atmospheric plasma (CAP) technology — a partially ionised gas produced at near-body-temperature that delivers a cocktail of reactive oxygen species, reactive nitrogen species, UV photons, and electromagnetic fields to target tissue without thermal damage. Unlike high-temperature plasma used in industrial settings, CAP operates at or below 40°C, making it safe for direct skin and tissue contact. At REGEVITA the device is used across a spectrum of applications: supporting cellular regeneration in the dermis, reducing localised inflammation in joints and soft tissue, stimulating immune modulation, improving skin firmness and tone, and enhancing post-exercise recovery in athletes. The clinic positions it as one of its core biohacking technologies for longevity-oriented clients.

The Human Regenerator Power Jet is the flagship regenerative device at REGEVITA's Praha 8 centre, applying cold atmospheric plasma — a fourth state of matter — in a controlled clinical protocol. Cold atmospheric plasma is generated by passing a gas (typically helium or argon mixed with ambient air) through an electric field at atmospheric pressure, which partially ionises the gas without raising its bulk temperature. The resulting plasma contains a complex mixture of reactive species: superoxide anion (O₂⁻), hydroxyl radical (·OH), hydrogen peroxide (H₂O₂), nitric oxide (·NO), and peroxynitrite — alongside short-wavelength UV photons and oscillating electromagnetic fields. This combination gives CAP a uniquely broad biological effect profile that no single pharmaceutical or physical therapy can replicate. At the cellular level, the transient oxidative signal generated by CAP activates nuclear factor erythroid 2-related factor 2 (Nrf2), the master transcription factor for endogenous antioxidant enzyme synthesis. This counterintuitive mechanism — a controlled oxidative stimulus triggering a stronger antioxidant response — is similar to the hormetic effect of exercise and is distinct from the sustained oxidative damage of pathological inflammation. Simultaneously, reactive nitrogen species from the plasma generate nitric oxide in treated tissue, promoting vasodilation and improved local perfusion. In dermatological applications, CAP has been shown to stimulate fibroblast proliferation and collagen synthesis, reduce melanin overproduction, and modulate the skin microbiome without chemical sensitisers. In musculoskeletal contexts, the anti-inflammatory and microcirculatory effects support tissue repair after injury or overuse. The device's electromagnetic field component may additionally support mitochondrial function in the treated tissue. At REGEVITA, the Human Regenerator is used both as a standalone biohacking session and as a component of physiotherapy appointments, where the physiotherapist integrates it alongside manual therapy for post-injury rehabilitation or chronic degenerative conditions. Session protocols are personalised by the clinical team based on the patient's goals — cosmetic firming, athletic recovery, immune modulation, or longevity maintenance. Contraindications include active infection at the treatment site, implanted electronic devices, and pregnancy.